What are the latest recommended treatment options for Leber congenital amaurosis?
Gene therapies offer targeted treatment options for Leber congenital amaurosis, with Luxturna being the approved treatment for RPE65 mutations and various emerging therapies under investigation for CEP290 and other subtypes. Each therapy's application depends on specific genetic mutations, emphasizing the importance of genetic testing in management decisions.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-04
- DOI
- https://doi.org/10.5281/zenodo.23956354
- Primary Topic
- Retinal Development and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00